PHOundry Pharmaceuticals' Seed VC Round

PHOundry Pharmaceuticals raised a round of funding on August 06, 2015. Investors include Pappas Ventures.

PHOundry Pharmaceuticals is focusing upon discovery of high-potency, peptidase-resistant peptide therapeutics with high druggability.…

Articles about PHOundry Pharmaceuticals' Seed VC Round: